Examiner: MIKNIS, ZACHARY J

Tech Center 1600 • Art Units: 1654 1658 1674 1675

This examiner grants 68% of resolved cases

Performance Statistics

68.3%

Allow Rate

+8.3% vs TC avg

671

Total Applications

+32.5%

Interview Lift

957

Avg Prosecution Days

Based on 643 resolved cases, 2023–2026

6.6%

§101 Eligibility

14.8%

§102 Novelty

28.1%

§103 Obviousness

33.4%

§112 Clarity

App #	Title	Status	Assignee
19354492	ANTIMICROBIAL HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF USING THE SAME	Final Rejection	Rochal Technologies, LLC
18292488	Isthmin Protein Therapeutics for the Treatment of Non-Alcoholic Fatty Liver Disease	Non-Final OA	The Board of Trustees of the Leland Stanford Junior University
19323313	NOVEL LIGHT-ACTIVATED CHANNEL PROTEIN VR3.0 AND USES THEREOF	Non-Final OA	ZHONGMOU THERAPEUTICS CO., LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.